Works matching Interleukins (IL)

Results: 5000

Impact of Treatment Interruption on the Effectiveness of Interleukin (IL)-17A Inhibitors in Plaque Psoriasis: A Retrospective Analysis.

Published in:

International Journal of General Medicine, 2025, v. 18, p. 1681, doi. 10.2147/IJGM.S515389

By:

Jiang, Jin;
Zhang, Meihua;
Li, Mi

Publication type:

Article

Expression of interleukin ( IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study.

Published in:

Clinical & Experimental Immunology, 2014, v. 177, n. 1, p. 64, doi. 10.1111/cei.12285

By:

Fonseca‐Camarillo, G.;
Furuzawa‐Carballeda, J.;
Granados, J.;
Yamamoto‐Furusho, J. K.

Publication type:

Article

Follicular fluid and serum vascular endothelial growth factor, interleukin (IL)-1β and glycodelin concentrations: comparison between long-gonadotropin-releasing hormone (GnRH)-agonist and GnRH-antagonist cycles: a randomized controlled trial.

Published in:

Gynecological Endocrinology, 2014, v. 30, n. 10, p. 734, doi. 10.3109/09513590.2014.929655

By:

Aydin, Yunus;
Hassa, Hikmet;
Isikci, Tugba;
Colak, Omer

Publication type:

Article

NLRP3-Dependent and -Independent Processing of Interleukin (IL)-1β in Active Ulcerative Colitis.

Published in:

International Journal of Molecular Sciences, 2019, v. 20, n. 1, p. 57, doi. 10.3390/ijms20010057

By:

Ranson, Nicole;
Veldhuis, Mark;
Mitchell, Brent;
Fanning, Scott;
Cook, Anthony L.;
Kunde, Dale;
Eri, Rajaraman

Publication type:

Article

Expression of Interleukin (IL)-10, IL-17A and IL-22 in Serum and Sputum of Stable Chronic Obstructive Pulmonary Disease Patients.

Published in:

COPD: Journal of Chronic Obstructive Pulmonary Disease, 2013, v. 10, n. 4, p. 459, doi. 10.3109/15412555.2013.770456

By:

Zhang, Li;
Cheng, Zhenshun;
Liu, Weimin;
Wu, Kaisong

Publication type:

Article

The Emerging Role of Interleukin-(IL)-11/IL-11R in Bone Metabolism and Homeostasis: From Cytokine to Osteokine.

Published in:

Aging & Disease, 2023, v. 14, n. 6, p. 2113, doi. 10.14336/AD.2023.0306

By:

Bingzi Dong;
Jingjing Zhu;
Xian Chen;
Hongyuan Jiang;
Yujie Deng;
Lili Xu;
Yangang Wang;
Shufa Li

Publication type:

Article

Effects of interleukin ( IL)-6 gene polymorphisms on recurrent aphthous stomatitis.

Published in:

Archives of Dermatological Research, 2014, v. 306, n. 2, p. 173, doi. 10.1007/s00403-013-1406-x

By:

Karakus, Nevin;
Yigit, Serbulent;
Rustemoglu, Aydin;
Kalkan, Goknur;
Bozkurt, Nihan

Publication type:

Article

Analysis of serum interleukin(IL)‐1α, IL‐1β and IL‐18 in patients with systemic sclerosis.

Published in:

Clinical & Translational Immunology, 2019, v. 8, n. 4, p. N.PAG, doi. 10.1002/cti2.1045

By:

Lin, Emily;
Vincent, Fabien B;
Sahhar, Joanne;
Ngian, Gene‐Siew;
Kandane‐Rathnayake, Rangi;
Mende, Rachel;
Morand, Eric F;
Lang, Tali;
Harris, James

Publication type:

Article

Roles of interleukin (IL)-6 gene polymorphisms, serum IL-6 levels, and treatment in obstructive sleep apnea: a meta-analysis.

Published in:

Sleep & Breathing, 2016, v. 20, n. 2, p. 719, doi. 10.1007/s11325-015-1288-6

By:

Zhong, Anyuan;
Xiong, Xiaolu;
Shi, Minhua;
Xu, Huajun

Publication type:

Article

Interleukin (IL)-21 in Inflammation and Immunity During Parasitic Diseases.

Published in:

Frontiers in Cellular & Infection Microbiology, 2019, v. 9, p. 1, doi. 10.3389/fcimb.2019.00401

By:

Solaymani-Mohammadi, Shahram;
Eckmann, Lars;
Singer, Steven M.

Publication type:

Article

Prevalence of the −295 T-to-C promoter polymorphism of the interleukin (IL)-16 gene in periodontitis.

Published in:

Clinical & Experimental Immunology, 2005, v. 142, n. 1, p. 188, doi. 10.1111/j.1365-2249.2005.02902.x

By:

Folwaczny, M.;
Glas, J.;
Török, H.-P.;
Tonenchi, L.;
Paschos, E.;
Malachova, O.;
Bauer, B.;
Folwaczny, C.

Publication type:

Article

Interleukin (IL)-6, interleukin (IL)-8 levels and cellular composition of the vitreous humor in proliferative diabetic retinopathy, proliferative vitreoretinopathy, and traumatic proliferative vitreoretinopathy.

Published in:

2005

By:

Canataroglu, Hatice;
Varinli, Ilter;
Ozcan, Altan A.;
Canataroglu, Abdullah;
Doran, Figen;
Varinli, Seyhan

Publication type:

journal article

Hepatic expression of the tumor necrosis factor family member lymphotoxin-β is regulated by interleukin (IL)-6 and IL-1β: transcriptional control mechanisms in oval cells and hepatoma cell lines.

Published in:

Liver International, 2005, v. 25, n. 3, p. 633, doi. 10.1111/j.1478-3231.2005.01080.x

By:

Subrata, Lily S.;
Lowes, Kim N.;
Olynyk, John K.;
Yeoh, George C. T.;
Quail, Elizabeth A.;
Abraham, Lawrence J.

Publication type:

Article

Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry.

Published in:

Pediatric Allergy & Immunology, 2004, v. 15, n. 1, p. 79, doi. 10.1046/j.0905-6157.2003.00103.x

By:

Syh-Jae Lin;
Po-Jen Cheng;
Yun-Jun Huang, Bodo;
Ming-Ling Kuo

Publication type:

Article

Signalling of multiple interleukin (IL)‐17 family cytokines via IL‐17 receptor A drives psoriasis‐related inflammatory pathways.

Published in:

British Journal of Dermatology, 2021, v. 185, n. 3, p. 585, doi. 10.1111/bjd.20090

By:

Tollenaere, M.A.X.;
Hebsgaard, J.;
Ewald, D.A.;
Lovato, P.;
Garcet, S.;
Li, X.;
Pilger, S.D.;
Tiirikainen, M.L.;
Bertelsen, M.;
Krueger, J.G.;
Norsgaard, H.

Publication type:

Article

Induction of interleukin (IL)-1β, IL-10, IL-8 and immunoglobulin G by Porphyromonas gingivalis HmuY in humans.

Published in:

2012

By:

Trindade, S. C.;
Olczak, T.;
Gomes-Filho, I. S.;
Moura-Costa, L. F.;
Cerqueira, E. M. M.;
Galdino-Neto, M.;
Alves, H.;
Carvalho-Filho, P. C.;
Xavier, M. T.;
Meyer, R.

Publication type:

Journal Article

Induction of interleukin (IL)-1β, IL-10, IL-8 and immunoglobulin G by Porphyromonas gingivalis HmuY in humans.

Published in:

Journal of Periodontal Research, 2012, v. 47, n. 1, p. 27, doi. 10.1111/j.1600-0765.2011.01401.x

By:

Trindade, S. C.;
Olczak, T.;
Gomes‐Filho, I. S.;
Moura‐Costa, L. F.;
Cerqueira, E. M. M.;
Galdino‐Neto, M.;
Alves, H.;
Carvalho‐Filho, P. C.;
Xavier, M. T.;
Meyer, R.

Publication type:

Article

Cerebral microdialysis of interleukin (IL)-1ß and IL-6: extraction efficiency and production in the acute phase after severe traumatic brain injury in rats.

Published in:

Acta Neurochirurgica, 2008, v. 150, n. 12, p. 1277, doi. 10.1007/s00701-008-0151-y

By:

Folkersma, Hedy;
Brevé, John;
Tilders, Fred;
Cherian, Leela;
Robertson, Claudia;
Vandertop, W.

Publication type:

Article

Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumors.

Published in:

Molecular & Cellular Biochemistry, 2007, v. 304, n. 1/2, p. 343, doi. 10.1007/s11010-007-9517-3

By:

Vassilis Samaras;
Christina Piperi;
Penelope Korkolopoulou;
Athanasios Zisakis;
Georgia Levidou;
Marios Themistocleous;
Efstathios Boviatsis;
Damianos Sakas;
Robert Lea;
Anastasios Kalofoutis;
Efstratios Patsouris

Publication type:

Article

Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1 β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients

Published in:

Clinical & Experimental Immunology, 2015, v. 182, n. 1, p. 35, doi. 10.1111/cei.12667

By:

Ruscitti, P.;
Cipriani, P.;
Di Benedetto, P.;
Liakouli, V.;
Berardicurti, O.;
Carubbi, F.;
Ciccia, F.;
Alvaro, S.;
Triolo, G.;
Giacomelli, R.

Publication type:

Article

Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.

Published in:

Clinical & Experimental Immunology, 2015, v. 181, n. 2, p. 253, doi. 10.1111/cei.12639

By:

Cai, Z.;
Wong, C. K.;
Dong, J.;
Chu, M.;
Jiao, D.;
Kam, N. W.;
Lam, C. W. K.;
Tam, L. S.

Publication type:

Article

Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18.

Published in:

Clinical & Experimental Immunology, 2015, v. 181, n. 2, p. 219, doi. 10.1111/cei.12643

By:

Ciccia, F.;
Guggino, G.;
Rizzo, A.;
Bombardieri, M.;
Raimondo, S.;
Carubbi, F.;
Cannizzaro, A.;
Sireci, G.;
Dieli, F.;
Campisi, G.;
Giacomelli, R.;
Cipriani, Paola;
De Leo, G.;
Alessandro, R.;
Triolo, G.

Publication type:

Article

Association of polymorphisms in interleukin ( IL)-12 A and - B genes with rheumatoid arthritis in a Chinese population.

Published in:

Clinical & Experimental Immunology, 2015, v. 180, n. 1, p. 83, doi. 10.1111/cei.12563

By:

Wang, E‐Y.;
Yang, Q.;
Liao, Z‐G.

Publication type:

Article

Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-γ by CD4+ T cells in patients with inflammatory arthritis.

Published in:

Clinical & Experimental Immunology, 2015, v. 179, n. 3, p. 378, doi. 10.1111/cei.12434

By:

Wu, C.;
Goodall, J. C.;
Busch, R.;
Gaston, J. S. H.

Publication type:

Article

Functional relevance of NLRP3 inflammasome-mediated interleukin ( IL)-1β during acute allergic airway inflammation.

Published in:

Clinical & Experimental Immunology, 2014, v. 178, n. 2, p. 212, doi. 10.1111/cei.12400

By:

Ritter, M.;
Straubinger, K.;
Schmidt, S.;
Busch, D. H.;
Hagner, S.;
Garn, H.;
Prazeres da Costa, C.;
Layland, L. E.

Publication type:

Article

Engagement of Toll-like receptor 2 enhances interleukin ( IL)-17+ autoreactive T cell responses via p38 mitogen-activated protein kinase signalling in dendritic cells.

Published in:

Clinical & Experimental Immunology, 2014, v. 178, n. 2, p. 353, doi. 10.1111/cei.12405

By:

Wei, R.;
Dong, L.;
Xiao, Q.;
Sun, D.;
Li, X.;
Nian, H.

Publication type:

Article

Interleukin (IL)-17 A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis.

Published in:

Clinical & Experimental Immunology, 2014, v. 177, n. 3, p. 652, doi. 10.1111/cei.12376

By:

Sarkar, S.;
Justa, S.;
Brucks, M.;
Endres, J.;
Fox, D. A.;
Zhou, X.;
Alnaimat, F.;
Whitaker, B.;
Wheeler, J. C.;
Jones, B. H.;
Bommireddy, S. R.

Publication type:

Article

Immunoregulation therapy changes the frequency of interleukin (IL)-22+ CD4+ T cells in systemic lupus erythematosus patients.

Published in:

Clinical & Experimental Immunology, 2014, v. 177, n. 1, p. 212, doi. 10.1111/cei.12330

By:

Zhao, L.;
Ma, H.;
Jiang, Z.;
Jiang, Y.;
Ma, N.

Publication type:

Article

Endogenous interleukin ( IL)-17 A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.

Published in:

Clinical & Experimental Immunology, 2014, v. 176, n. 3, p. 341, doi. 10.1111/cei.12287

By:

Summers, S. A.;
Odobasic, D.;
Khouri, M. B.;
Steinmetz, O. M.;
Yang, Y.;
Holdsworth, S. R.;
Kitching, A. R.

Publication type:

Article

Neuroprotection effect of interleukin (IL)-17 secreted by reactive astrocytes is emerged from a high-level IL-17-containing environment during acute neuroinflammation.

Published in:

Clinical & Experimental Immunology, 2014, v. 175, n. 2, p. 268, doi. 10.1111/cei.12219

By:

Hu, M. H.;
Zheng, Q. F.;
Jia, X. Z.;
Li, Y.;
Dong, Y. C.;
Wang, C. Y.;
Lin, Q. Y.;
Zhang, F. Y.;
Zhao, R. B.;
Xu, H. W.;
Zhou, J. H.;
Yuan, H. P.;
Zhang, W. H.;
Ren, H.

Publication type:

Article

Possible pathogenic role of T helper type 9 cells and interleukin ( IL)-9 in atopic dermatitis.

Published in:

Clinical & Experimental Immunology, 2014, v. 175, n. 1, p. 25, doi. 10.1111/cei.12198

By:

Ma, L.;
Xue, H.‐B.;
Guan, X.‐H.;
Shu, C.‐M.;
Zhang, J.‐H.;
Yu, J.

Publication type:

Article

Enhanced and persistent levels of interleukin ( IL)-17+ CD4+ T cells and serum IL-17 in patients with early inflammatory arthritis.

Published in:

Clinical & Experimental Immunology, 2013, v. 174, n. 2, p. 292, doi. 10.1111/cei.12167

By:

Gullick, N. J.;
Abozaid, H. S.;
Jayaraj, D. M.;
Evans, H. G.;
Scott, D. L.;
Choy, E. H.;
Taams, L. S.

Publication type:

Article

Experimentally induced psoriatic lesion associates with interleukin (IL)-6 in mast cells and appearance of dermal cells expressing IL-33 and IL-6 receptor.

Published in:

Clinical & Experimental Immunology, 2012, v. 169, n. 3, p. 311, doi. 10.1111/j.1365-2249.2012.04618.x

By:

Suttle, M.-M.;
Nilsson, G.;
Snellman, E.;
Harvima, I. T.

Publication type:

Article

Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1.

Published in:

Clinical & Experimental Immunology, 2012, v. 167, n. 3, p. 391, doi. 10.1111/j.1365-2249.2011.04533.x

By:

Goldbach-Mansky, R.

Publication type:

Article

Comparison of interferon-γ-, interleukin (IL)-17- and IL-22-expressing CD4 T cells, IL-22-expressing granulocytes and proinflammatory cytokines during latent and active tuberculosis infection.

Published in:

Clinical & Experimental Immunology, 2012, v. 167, n. 2, p. 317, doi. 10.1111/j.1365-2249.2011.04520.x

By:

Cowan, J.;
Pandey, S.;
Filion, L. G.;
Angel, J. B.;
Kumar, A.;
Cameron, D. W.

Publication type:

Article

Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis.

Published in:

Clinical & Experimental Immunology, 2011, v. 166, n. 3, p. 346, doi. 10.1111/j.1365-2249.2011.04468.x

By:

Barlo, N. P.;
van Moorsel, C. H. M.;
Korthagen, N. M.;
Heron, M.;
Rijkers, G. T.;
Ruven, H. J. T.;
van den Bosch, J. M. M.;
Grutters, J. C.

Publication type:

Article

Intracellular bacteria recognition contributes to maximal interleukin (IL)-12 production by IL-10-deficient macrophages.

Published in:

Clinical & Experimental Immunology, 2011, v. 164, n. 1, p. 137, doi. 10.1111/j.1365-2249.2011.04318.x

By:

Naruse, H.;
Hisamatsu, T.;
Yamauchi, Y.;
Chang, J. E.;
Matsuoka, K.;
Kitazume, M. T.;
Arai, K.;
Ando, S.;
Kanai, T.;
Kamada, N.;
Hibi, T.

Publication type:

Article

Association of adiponectin, interleukin (IL)-1ra, inducible protein 10, IL-6 and number of islet autoantibodies with progression patterns of type 1 diabetes the first year after diagnosis.

Published in:

Clinical & Experimental Immunology, 2010, v. 161, n. 3, p. 444, doi. 10.1111/j.1365-2249.2010.04193.x

By:

Kaas, A.;
Pfleger, C.;
Hansen, L.;
Buschard, K.;
Schloot, N. C.;
Roep, B. O.;
Mortensen, H. B.

Publication type:

Article

Inhibition of transforming growth factor-β signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.

Published in:

Clinical & Experimental Immunology, 2010, v. 160, n. 3, p. 394, doi. 10.1111/j.1365-2249.2010.04094.x

By:

Segawa, S.;
Goto, D.;
Yoshiga, Y.;
Sugihara, M.;
Hayashi, T.;
Chino, Y.;
Matsumoto, I.;
Ito, S.;
Sumida, T.

Publication type:

Article

Patients with inflammatory bowel disease may have a transforming growth factor-β-, interleukin (IL)-2- or IL-10-deficient state induced by intrinsic neutralizing antibodies.

Published in:

Clinical & Experimental Immunology, 2009, v. 155, n. 1, p. 65, doi. 10.1111/j.1365-2249.2008.03802.x

By:

Ebert, E. C.;
Panja, A.;
Das, K. M.;
Praveen, R.;
Geng, X.;
Rezac, C.;
Bajpai, M.

Publication type:

Article

Non-obese diabetic–recombination activating gene-1 (NOD– Rag 1 null) interleukin (IL)-2 receptor common gamma chain ( IL 2 rγ null) null mice: a radioresistant model for human lymphohaematopoietic engraftment.

Published in:

Clinical & Experimental Immunology, 2008, v. 154, n. 2, p. 270, doi. 10.1111/j.1365-2249.2008.03753.x

By:

Pearson, T.;
Shultz, L. D.;
Miller, D.;
King, M.;
Laning, J.;
Fodor, W.;
Cuthbert, A.;
Burzenski, L.;
Gott, B.;
Lyons, B.;
Foreman, O.;
Rossini, A. A.;
Greiner, D. L.

Publication type:

Article

Suppression of lipopolysaccharide- and tumour necrosis factor-α-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation.

Published in:

Clinical & Experimental Immunology, 2007, v. 150, n. 1, p. 151, doi. 10.1111/j.1365-2249.2007.03484.x

By:

Tsaprouni, L. G.;
Ito, K.;
Adcock, I. M.;
Punchard, N.

Publication type:

Article

Polymorphisms of interleukin (IL)-4 receptor alpha and signal transducer and activator of transcription-6 (Stat6) are associated with increased IL-4Rα–Stat6 signalling in lymphocytes and elevated serum IgE in patients with Graves' disease.

Published in:

Clinical & Experimental Immunology, 2007, v. 148, n. 3, p. 425, doi. 10.1111/j.1365-2249.2007.03366.x

By:

Yabiku, K.;
Hayashi, M.;
Komiya, I.;
Yamada, T.;
Kinjo, Y.;
Ohshiro, Y.;
Kouki, T.;
Takasu, N.

Publication type:

Article

Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease.

Published in:

Clinical & Experimental Immunology, 2007, v. 147, n. 2, p. 287, doi. 10.1111/j.1365-2249.2006.03283.x

By:

Nielsen, C. H.;
Hegedüs, L.;
Rieneck, K.;
Moeller, A. C.;
Leslie, R. G. Q.;
Bendtzen, K.

Publication type:

Article

Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.

Published in:

Clinical & Experimental Immunology, 2006, v. 145, n. 3, p. 535, doi. 10.1111/j.1365-2249.2006.03145.x

By:

Coma, G.;
Peña, R.;
Blanco, J.;
Rosell, A.;
Borras, F. E.;
Esté, J. A.;
Clotet, B.;
Ruiz, L.;
Parkhouse, R. M. E.;
Bofill, M.

Publication type:

Article

Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-Jun NH2-terminal kinase 1/2 signalling pathways

Published in:

Clinical & Experimental Immunology, 2006, v. 145, n. 1, p. 162, doi. 10.1111/j.1365-2249.2006.03085.x

By:

Ip, W. K.;
Wong, C. K.;
Lam, Christopher W. K.

Publication type:

Article

Elevated serum interleukin (IL)-12p40 levels in common variable immunodeficiency disease and decreased peripheral blood dendritic cells: analysis of IL-12p40 and interferon-γ gene.

Published in:

Clinical & Experimental Immunology, 2006, v. 144, n. 2, p. 233, doi. 10.1111/j.1365-2249.2006.03063.x

By:

Martinez-Pomar, N.;
Raga, S.;
Ferrer, J.;
Pons, J.;
Munoz-Saa, I.;
Julia, M.-R.;
de Gracia, J.;
Matamoros, N.

Publication type:

Article

Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway.

Published in:

Clinical & Experimental Immunology, 2006, v. 144, n. 2, p. 247, doi. 10.1111/j.1365-2249.2006.03076.x

By:

Yang, Y.-H.;
Huang, Y.-H.;
Lin, Y.-L.;
Wang, L.-C.;
Chuang, Y.-H.;
Yu, H.-H.;
Lin, Y.-T.;
Chiang, B.-L.

Publication type:

Article

Interleukin (IL)-2 and IL-12 responses to Chlamydia trachomatis infection in adolescents.

Published in:

Clinical & Experimental Immunology, 2005, v. 142, n. 3, p. 548, doi. 10.1111/j.1365-2249.2005.02946.x

By:

Wang, C.;
Tang, J.;
Crowley-Nowick, P. A.;
Wilson, C. M.;
Kaslow, R. A.;
Geisler, W. M.

Publication type:

Article

Strikingly higher interleukin (IL)-1α, IL-1β and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-α, transforming growth factor (TGF)-β2 and interferon IFN-γ urine levels in healthy females compared to healthy males: protection against urinary tract injury?

Published in:

Clinical & Experimental Immunology, 2005, v. 142, n. 2, p. 312, doi. 10.1111/j.1365-2249.2005.02924.x

By:

Sadeghi, M.;
Daniel, V.;
Naujokat, C.;
Weimer, R.;
Opelz, G.

Publication type:

Article